National LTC Pharmacy Group Praises SFC Momentum on PBM Rebate Transparency
Positive Grassley Sentiment on Greater PBM Transparency Draws Support from SCPC…Read More.
Congresswoman Suzan DelBene Visits Long-Term Care Pharmacy
Consonus Health Pharmacy Visit Showcases Differences Between Long-term Care and Retail Pharmacies for Federal Lawmaker…Read More.
National LTC Pharmacy Group: Senate, House Drug Pricing Hearings Kick-Off Vital 2019 Discussion on Transparency, Accountability, Reform
SCPC Urges Sweeping Congressional Focus on PDP/PBM Abuses, Culpability in Market Manipulation…Read More.
National LTC Pharmacy Group to CMS: Abolish DIR Fees – “A Windfall Profit” for Prescription Drug Plans (PDPs) and Pharmacy Benefit Managers (PBMs)
Citing Unique Nature of LTC Pharmacies and Elderly Patients They Serve, Senior Care Pharmacy Coalition (SCPC) Viewpoint on DIR Fees Differs from Other Pharmacy Sector Groups…Read More.
Comment Letter: CMS Proposed Rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses
RE: CMS Proposed Rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, CMS 4180-P, RIN 0938-AT92, 83 Fed. Reg. 62152…Read More.
Grassley’s Longtime Focus on Transparency Praised by National LTC Pharmacy Advocacy Group as Senator Assumes Senate Finance Committee Chairmanship
New WSJ Report on Part D Medicare Plans Overcharging CMS Ripe Target for Scrutiny…Read More.
Completion of CVS Health-Aetna Merger Underscores Importance to Seniors of Scrutinizing Proposed CMS Drug Pricing Rule
National LTC Pharmacy Advocacy Group Warns Health Industry Consolidation Crushing Choice, Competition at Expense of Senior Consumers…Read More.
SCPC Expresses Concern Proposed CMS Rule Threatens Seniors’ Access to Essential Medications, Further Undermines LTC Pharmacy Economic Viability
The Senior Care Pharmacy Coalition (SCPC) today said its initial review of the Centers for Medicare and Medicaid Services (CMS) proposed changes to Medicare Advantage and Part D programs…Read More.
CVS and Aetna merger a disruptive sign of the future
The proposed CVS Health-Aetna merger is emblematic of the growing arms race to consolidate and control consumer access to appropriate prescription drugs, particularly LTC (long-term care) patients…Read More.
CVS Health-Aetna Merger Emblematic of Growing Arms Race to Consolidate, Control Seniors’ Access to Prescription Drugs
The proposed CVS Health-Aetna merger is emblematic of the growing arms race to consolidate and control consumer access to appropriate prescription drugs, particularly LTC patients…Read More.